Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NTRA | Common Stock | Sale | -$201K | -5K | -1.03% | $40.23 | 480K | Nov 2, 2023 | Direct | F1, F2 |
transaction | NTRA | Common Stock | Sale | -$20.2K | -500 | -2.21% | $40.47 | 22.2K | Nov 2, 2023 | By Caraluna 1 Trust | F2, F3, F4, F5 |
transaction | NTRA | Common Stock | Sale | -$20.1K | -500 | -2.21% | $40.23 | 22.2K | Nov 2, 2023 | By Caraluna 2 Trust | F2, F3, F5 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. The Reporting Person is subject to a Lock-up Letter Agreement that expires on November 5, 2023. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement. |
F2 | These reported shares are subject to restrictions in the Lock-Up Letter Agreement. |
F3 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. The Reporting Person is subject to a Lock-up Letter Agreement that expires on November 5, 2023. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement. |
F4 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.23 to $40.72 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F5 | Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. |